PMV Pharmaceuticals, Inc. (PMVP) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-06-05

PMV Pharmaceuticals, Inc. (PMVP) has filed 5 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-05. 2 Form 8-K material event filings were reported by PMVP in the last 90 days. InsiderAlpha tracks every PMVP SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About PMV Pharmaceuticals, Inc. (PMVP)

SEC CIK	0001699382

90-Day SEC Filing Activity

Form 4 filings (90d)	5
Form 8-K filings (90d)	2
Latest Form 4 filing	2026-06-05

Recent PMVP Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2025-10-23	ORBIMED ADVISORS LLC	10% Owner	S — Open-market sale	1.00M	$1.52	$1.52M	SEC
2025-09-10	ORBIMED ADVISORS LLC	10% Owner	S — Open-market sale	500.0K	$1.80	$900K	SEC
2025-07-01	Mack David Henry	President and CEO	S — Open-market sale	58.4K	$1.06	$62K	SEC
2025-07-01	Ticktin Robert	General Counsel COO	S — Open-market sale	23.2K	$1.06	$25K	SEC
2025-07-01	Carulli Michael	Chief Financial Officer	S — Open-market sale	28.2K	$1.06	$30K	SEC
2025-07-01	Jalota Deepika	Chief Development Officer	S — Open-market sale	33.1K	$1.06	$35K	SEC

All transactions sourced from SEC EDGAR Form 4 filings for PMV Pharmaceuticals, Inc. (PMVP). Updated in real time as new filings are submitted to the SEC.

Most-Active PMVP Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
Gallagher Carol Giltner	3	—
LEVINE ARNOLD J	1	—
Stelzer Laurie	1	—
BAUM CHARLES M	1	—
FLOWERS KIRSTEN	1	—

Recent PMVP Form 8-K Material Events

2026-06-05 — Item 5.07 [SEC]
2026-05-12 — Item 2.02, 9.01 [SEC]
2026-03-06 — Item 2.02, 9.01 · Earnings · neutral [SEC]
PMV Pharmaceuticals announced its financial results for the year ended December 31, 2025 via press release on March 6, 2026. The filing provides standard annual financial reporting without explicit beat/miss language or forward guidance changes.

Recent Insider Filings

2026-06-05 — Stelzer Laurie (Insider)
2026-06-05 — LEVINE ARNOLD J (Insider)
2026-06-05 — Gallagher Carol Giltner (Insider)
2026-06-05 — FLOWERS KIRSTEN (Insider)
2026-06-05 — BAUM CHARLES M (Insider)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in PMVP insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

PMVP Insider Trading — FAQ

What is the latest insider trade for PMVP?: PMV Pharmaceuticals, Inc. (PMVP) had 5 insider filings in the last 90 days, with the most recent on 2026-06-05. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying PMVP stock?: 0 insider purchases of PMVP were filed in the last 90 days.
How many insiders are selling PMVP stock?: 0 insider sales of PMVP were filed in the last 90 days.
Where can I see PMVP SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every PMVP SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live PMVP dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.